US 8623383
Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
granted A61KA61K39/00
Quick answer
US patent 8623383 (Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae) held by United States of America as represented by the Secretary of the Air Force expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K39/00